{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:01:16Z","timestamp":1753887676295,"version":"3.41.2"},"reference-count":32,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"DOI":"10.1590\/0074-02760190062","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T19:30:18Z","timestamp":1564860618000},"source":"Crossref","is-referenced-by-count":4,"title":["Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model"],"prefix":"10.1590","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6888-7857","authenticated-orcid":false,"given":"Yasmine Amr","family":"Issa","sequence":"first","affiliation":[{"name":"University of Alexandria,  Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar Nabil","family":"El Achy","sequence":"additional","affiliation":[{"name":"University of Alexandria,  Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha Fadly","family":"Mady","sequence":"additional","affiliation":[{"name":"University of Alexandria,  Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2019]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001600","article-title":"Nigeria \"Ground Zero\" for the high prevalence neglected tropical diseases","volume":"6","author":"Hotez PJ","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"9541","key":"ref2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human schistosomiasis","volume":"368","author":"Gryseels B","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/medicines5020052","article-title":"The role of cannabinoids in the setting of cirrhosis","volume":"5","author":"Dibba P","year":"2018","journal-title":"Medicines (Basel)"},{"issue":"32","key":"ref4","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako K","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc F","year":"2006","journal-title":"Nat Med"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000445269","article-title":"New developments on the treatment of liver fibrosis","volume":"34","author":"Koyama Y","year":"2016","journal-title":"Dig Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2014.03.015","article-title":"Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J infection: role of NADPH oxidase","volume":"71","author":"Wang M","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ph11010015","article-title":"Drug Repurposing for schistosomiasis combinations of drugs or biomolecules","volume":"11","author":"Gouveia MJ","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu HC","year":"2016","journal-title":"Biol Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijid.2017.03.008","article-title":"Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B","volume":"59","author":"Dai E","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2307\/3274166","article-title":"An efficient method for exposure of mice to cercariae of Schistosoma mansoni","volume":"38","author":"Olivier L","year":"1952","journal-title":"J Parasitol"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s00436-018-5972-x","article-title":"Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice","volume":"117","author":"Ma Z","year":"2018","journal-title":"Parasitol Res"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/labinvest.2011.191","article-title":"Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis","volume":"92","author":"Giannone FA","year":"2012","journal-title":"Lab Invest"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11596-009-0209-y","article-title":"Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis","volume":"29","author":"Liu H","year":"2009","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191031","article-title":"Alpha-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis","volume":"13","author":"Zhao W","year":"2018","journal-title":"PLoS One"},{"key":"ref16","first-page":"167","article-title":"The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies","volume":"5","author":"Xu J","year":"2014","journal-title":"Front Pharmacol"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12263","article-title":"The endocannabinoid system in advanced liver cirrhosis pathophysiological implication and future perspectives","volume":"33","author":"Baldassarre M","year":"2013","journal-title":"Liver Int"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.12673","article-title":"Review article the endocannabinoid system in liver disease, a potential therapeutic target","volume":"39","author":"Basu PP","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"23","key":"ref19","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte C","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system signaling and function in the central nervous system","volume":"19","author":"Zou S","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"G357","DOI":"10.1152\/ajpgi.00456.2007","article-title":"Endocannabinoids and liver disease II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis","volume":"294","author":"Siegmund SV","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11-12","key":"ref22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2119\/molmed.2011.00149","article-title":"Cannabinoid receptor type I modulates alcohol-induced liver fibrosis","volume":"17","author":"Patsenker E","year":"2011","journal-title":"Mol Med"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system","volume":"50","author":"Pacher P","year":"2011","journal-title":"Prog Lipid Res"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.21641","article-title":"Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa\/fa rats","volume":"46","author":"Gary-Bobo M","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale JP","year":"1998","journal-title":"J Clin Invest"},{"issue":"135","key":"ref26","first-page":"2052","article-title":"Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells","volume":"61","author":"Dai E","year":"2014","journal-title":"Hepatogastroenterology"},{"issue":"2-3","key":"ref27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","article-title":"Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa","volume":"86","year":"2003","journal-title":"Acta Trop"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2010.04.023","article-title":"Rimonabant-induced apoptosis in leukemia cell lines activation of caspase-dependent and -independent pathways","volume":"80","author":"Gallotta D","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref29","first-page":"432607","article-title":"Rimonabant From RIO to Ban","volume":"2011","author":"Sam AH","year":"2011","journal-title":"J Obes"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam J","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam J","year":"2012","journal-title":"Cell Metab"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87336","article-title":"Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis","volume":"1","author":"Cinar R","year":"2016","journal-title":"JCI Insight"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/mioc\/v114\/1678-8060-mioc-114-e190062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T23:37:03Z","timestamp":1581118623000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762019000100338&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":32,"alternative-id":["S0074-02762019000100338"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760190062","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"type":"electronic","value":"1678-8060"},{"type":"print","value":"0074-0276"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e190062"}}